Advertisement

Topics

PeptiDream Inc. Company Profile

20:27 EST 10th December 2018 | BioPortfolio

PeptiDream Inc. is a public (Tokyo Stock Exchange Mothers 4587) biopharmaceutical company founded in 2006 employing our proprietary Peptide Discovery Platform System (PDPS), a state-of-the-art highly versatile peptide generation and selection platform which enables the production of highly diverse (trillions) non-standard peptide libraries with high efficiency, for the discovery and development of best-in-class and first-in-class peptide-based therapeutics. PeptiDream aspires to be a world leader in the discovery and development of novel highly functional peptide therapeutics to address unmet medical needs and improve the quality of life of patients worldwide. For further information please visit www.peptidream.com


News Articles [7 Associated News Articles listed on BioPortfolio]

PeptiDream, Santen ally in ophthalmic diseases

PeptiDream Inc. and Santen Pharmaceutical Co. Ltd. are teaming up in the discovery and development of ophthalmic compounds.

PeptiDream Announces Drug Discovery and Development Agreement with Santen Pharmaceutical

PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today that it has entered into a broad-based multi-target discovery and...

Modulus Raises 800M Japanese Yen for Its Series A Funding Round

Modulus Discovery, Inc., an early stage drug discovery company announced today that it has successfully raised a total of 800M Japanese Yen (approximately US $7.2M) for its series...

Series B round brings $21mm to Kleo

Kleo Pharmaceuticals Inc. (immuno-oncology) raised $21mm through an oversubscribed Series B round led by PeptiDream (development partner under a 2017 deal) and including Biohaven Pharmaceuticals. The ...

PeptiDream Inc 4587 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17092018] Prices from USD $250

SummaryPeptiDream Inc PeptiDream is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptidedrug conjugate therapeutics. The company develops peptide d...

PeptiDream Inc 4587 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09052018] Prices from USD $250

SummaryPeptiDream Inc PeptiDream is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptidedrug conjugate therapeutics. The company develops peptide d...

PeptiDream Inc 4587 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryPeptiDream Inc PeptiDream is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptidedrug conjugate therapeutics. The company develops peptide d...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

PeptiDream Inc.

PeptiDream Inc. is a public (Tokyo Stock Exchange Mothers 4587) biopharmaceutical company founded in 2006 employing our proprietary Peptide Discovery Platform System (PDPS), a sta...

More Information about "PeptiDream Inc." on BioPortfolio

We have published hundreds of PeptiDream Inc. news stories on BioPortfolio along with dozens of PeptiDream Inc. Clinical Trials and PubMed Articles about PeptiDream Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PeptiDream Inc. Companies in our database. You can also find out about relevant PeptiDream Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record